A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
Condition: Wet Macular Degeneration Interventions: Drug: Faricimab; Drug: Aflibercept; Drug: Sham Procedure Sponsor: Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2019 Category: Research Source Type: clinical trials
